My personal Analyst Fair price minimum(worst case senario)-was over $6 and bracket ranges to $30. Once the Scoping study is completed(currently underway) we will have a much clearer idea of potential annual production. Once released we will see a significant risk reduction and associated re-rating.
If I was looking for a potential T/O this would be a pivotal inception point.
all the best